55 related articles for article (PubMed ID: 20043203)
1. Predictors of timely follow-up after abnormal cancer screening among women seeking care at urban community health centers.
Battaglia TA; Santana MC; Bak S; Gokhale M; Lash TL; Ash AS; Kalish R; Tringale S; Taylor JO; Freund KM
Cancer; 2010 Feb; 116(4):913-21. PubMed ID: 20052731
[TBL] [Abstract][Full Text] [Related]
2. Cervical cancer screening, abnormal results, and follow-up in women with substance use-related diagnoses.
Eastment MC; Gupta A; James J; Richardson BA; Pinder L; Kim HN; Wald A; Tsui JI
Subst Abus; 2022; 43(1):925-931. PubMed ID: 35289732
[No Abstract] [Full Text] [Related]
3. CORR Insights®: Are There Racial or Socioeconomic Disparities in Ambulatory Outcome or Survival After Oncologic Spine Surgery for Metastatic Cancer? Results From a Medically Underserved Center.
Fourman MS
Clin Orthop Relat Res; 2023 Feb; 481(2):308-311. PubMed ID: 36580477
[No Abstract] [Full Text] [Related]
4. Disparities in gynecologic cancer incidence, treatment, and survival: a narrative review of outcomes among black and white women in the United States.
Towner M; Kim JJ; Simon MA; Matei D; Roque D
Int J Gynecol Cancer; 2022 Jul; 32(7):931-938. PubMed ID: 35523443
[TBL] [Abstract][Full Text] [Related]
5. Adherence to follow-up after the exit cervical cancer screening test at age 60-64: A nationwide register-based study.
Jørgensen SF; Andersen B; Petersen LK; Rebolj M; Njor SH
Cancer Med; 2022 Jan; 11(1):224-237. PubMed ID: 34766466
[TBL] [Abstract][Full Text] [Related]
6. Determinants of Abnormal Cervical Cancer Screening Follow-Up And Invasive Cervical Cancer Among Uninsured and Underinsured Women in New Jersey.
Tsui J; Llanos AA; Doose M; Rotter D; Stroup A
J Health Care Poor Underserved; 2019; 30(2):680-701. PubMed ID: 31130545
[TBL] [Abstract][Full Text] [Related]
7. Timely follow-up of positive cancer screening results: A systematic review and recommendations from the PROSPR Consortium.
Doubeni CA; Gabler NB; Wheeler CM; McCarthy AM; Castle PE; Halm EA; Schnall MD; Skinner CS; Tosteson ANA; Weaver DL; Vachani A; Mehta SJ; Rendle KA; Fedewa SA; Corley DA; Armstrong K
CA Cancer J Clin; 2018 May; 68(3):199-216. PubMed ID: 29603147
[TBL] [Abstract][Full Text] [Related]
8. Rationale and design of the HOME trial: A pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system.
Winer RL; Tiro JA; Miglioretti DL; Thayer C; Beatty T; Lin J; Gao H; Kimbel K; Buist DSM
Contemp Clin Trials; 2018 Jan; 64():77-87. PubMed ID: 29113956
[TBL] [Abstract][Full Text] [Related]
9. Association of Financial Strain With Symptom Burden and Quality of Life for Patients With Lung or Colorectal Cancer.
Lathan CS; Cronin A; Tucker-Seeley R; Zafar SY; Ayanian JZ; Schrag D
J Clin Oncol; 2016 May; 34(15):1732-40. PubMed ID: 26926678
[TBL] [Abstract][Full Text] [Related]
10. Multiple barriers delay care among women with abnormal cancer screening despite patient navigation.
Ramachandran A; Freund KM; Bak SM; Heeren TC; Chen CA; Battaglia TA
J Womens Health (Larchmt); 2015 Jan; 24(1):30-6. PubMed ID: 25513858
[TBL] [Abstract][Full Text] [Related]
11. Follow-up and timeliness after an abnormal cancer screening among underserved, urban women in a patient navigation program.
Markossian TW; Darnell JS; Calhoun EA
Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1691-700. PubMed ID: 23045544
[TBL] [Abstract][Full Text] [Related]
12. Cervical cancer trends in the United States: a 35-year population-based analysis.
Adegoke O; Kulasingam S; Virnig B
J Womens Health (Larchmt); 2012 Oct; 21(10):1031-7. PubMed ID: 22816437
[TBL] [Abstract][Full Text] [Related]
13. Timeliness of cervical cancer diagnosis and initiation of treatment in the National Breast and Cervical Cancer Early Detection Program.
Benard VB; Howe W; Royalty J; Helsel W; Kammerer W; Richardson LC
J Womens Health (Larchmt); 2012 Jul; 21(7):776-82. PubMed ID: 22506920
[TBL] [Abstract][Full Text] [Related]
14. Sociodemographic factors associated with cervical cancer screening and follow-up of abnormal results.
Elit L; Krzyzanowska M; Saskin R; Barbera L; Razzaq A; Lofters A; Yeritsyan N; Bierman A
Can Fam Physician; 2012 Jan; 58(1):e22-31. PubMed ID: 22267636
[TBL] [Abstract][Full Text] [Related]
15. Timeliness and follow-up patterns of cervical cancer detection in a cohort of medically underserved California women.
Tabnak F; Müller HG; Wang JL; Zhang W; Howell LP
Cancer Causes Control; 2010 Mar; 21(3):411-20. PubMed ID: 20043203
[TBL] [Abstract][Full Text] [Related]
16. Cervical cancer screening in medically underserved California Latina and non-Latina women: effect of age and regularity of Pap testing.
Howell LP; Gurusinghe S; Tabnak F; Sciortino S
Cancer Detect Prev; 2009; 32(5-6):372-9. PubMed ID: 19264426
[TBL] [Abstract][Full Text] [Related]
17. Impact of ASC-H terminology on the detection of HSILs in medically underserved California women.
Howell LP; Gurusinghe S; Tabnak F
Diagn Cytopathol; 2009 Feb; 37(2):103-10. PubMed ID: 19021201
[TBL] [Abstract][Full Text] [Related]
18. An inpatient cervical cancer screening program to reach underserved women.
Richards LA; Klemm P
J Obstet Gynecol Neonatal Nurs; 2000; 29(5):465-73. PubMed ID: 11012125
[TBL] [Abstract][Full Text] [Related]
19. Overview of cervical cancer in the developing world. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.
Sankaranarayanan R
Int J Gynaecol Obstet; 2006 Nov; 95 Suppl 1():S205-10. PubMed ID: 17161159
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
